Which of the following treatments is NOT typically used for cardiogenic shock?

In the context of treating cardiogenic shock, it is essential to understand the role of each treatment option. Cardiogenic shock primarily occurs due to the heart's inability to pump sufficient blood, leading to inadequate tissue perfusion.

Aspirin and clopidogrel are antiplatelet medications that can be crucial during acute coronary syndromes, which may result in cardiogenic shock, to prevent further clot formation and improve blood flow. Morphine is often used in this context to relieve pain and decrease myocardial oxygen demand, which can help stabilize the patient.

In contrast, while IV fluids may be utilized in cases of hypovolemia or septic shock, their routine use in cardiogenic shock can be detrimental. Unlike other shock states, patients experiencing cardiogenic shock may already have enough intravascular volume; adding more fluid can potentially increase the workload on the heart, leading to further hemodynamic compromise. The focus in treating cardiogenic shock often shifts toward optimizing cardiac output and using vasopressors or inotropes rather than administering large volumes of IV fluids. Thus, the use of IV fluids is not standard in managing cardiogenic shock, making it the treatment option that is not typically used in this condition.